LEX-WK-NRCPX2BYcrawled 2026-02-05 16:29Z
HHS OIG Issues Guidance on Anti-Kickback Statute Implications for Direct-to-Consumer Drug Sales Ahead of TrumpRx Launch
Craig B. Bleifer · Jessica L. Vaughn, Ph.D. · The FCA Insider · Published February 5, 2026
Work details
- firm or organization
- McGuireWoods LLP
- publication
- The FCA Insider
- practice area
- Health Care and Life Sciences
- published
- 2026-02-05
Citation
Craig B. Bleifer, Jessica L. Vaughn, Ph.D., HHS OIG Issues Guidance on Anti-Kickback Statute Implications for Direct-to-Consumer Drug Sales Ahead of TrumpRx Launch, The FCA Insider (February 5, 2026) [The Library at LexBlog, LEX-WK-NRCPX2BY, lexpid.org/NRCPX2BY]